The 2026 update changes the Johnson & Johnson talcum powder fight from bankruptcy to a direct settlement. On July 27, 2026, the company proposed paying an estimated $5.5 billion to resolve about 76,000 ovarian-cancer lawsuits over Baby Powder and other talc products, as Reuters reported in the Missouri Lawyers Media account.
A mass tort here means thousands of individual injury lawsuits in federal and state courts that share evidence about the same products. That offer does not pay anyone in 2026. It sets terms, participation rules, and a payment schedule that readers can use to judge what happens next.
Official resources:
- Sokolove Law — Use this primary source to verify the official announcement.
- Missouri Lawyers Media — Use this primary source to verify the official announcement.
Table of Contents
- What the proposed deal would settle
- Why no one is paid in 2026
- Where the cases stand after bankruptcy
- What trial results tell claimants
- What to do if you used the powder
- What limits still apply to a claim
What the proposed deal would settle
The proposal covers ovarian and gynecologic claims only. It does not cover mesothelioma claims tied to talc. For mesothelioma, J&J says about 95% of filed suits are already settled, according to Sokolove Law.
The rest would continue as individual trials in state court. That split matters for families reading settlement headlines. Ovarian claimants fall under the new proposal, while mesothelioma claimants face a separate track.
Why no one is paid in 2026
The proposal is not final and cannot pay out this year. It requires at least 95% of remaining ovarian claimants to participate, according to the Johnson & Johnson news release carried by Stockwatch's release text. The first payment would be no more than $3 billion in 2027.
Later payments would depend on participation and final approval. Readers should treat 2026 as a decision period, not a payout period. Lawyers are counting clients, courts are waiting, and no checks move until the threshold is met.
Where the cases stand after bankruptcy
J&J tried to resolve talc claims through a prepackaged Chapter 11 case for Red River Talc LLC. Judge Christopher Lopez rejected that plan and dismissed the case on March 31, 2025, based on a Cadwalader analysis, finding voting defects and improper third-party releases. J&J did not appeal. The cases returned to regular federal and state courts.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
The federal docket remains very large. The Judicial Panel on Multidistrict Litigation reported 69,340 actions pending on Oct. 1, 2026 in MDL 2738 before Judge Michael Shipp, in the panel's pending-dockets report. MDL means many federal lawsuits are grouped before one judge for shared pretrial work, while each case keeps its own outcome.
What trial results tell claimants
Trials since the bankruptcy dismissal have split. A December 2025 Los Angeles jury awarded $40 million to two ovarian-cancer plaintiffs, according to Sokolove Law. A June 2026 Los Angeles bellwether went the other way, with a 10-2 defense verdict against three plaintiffs.
A bellwether is a test trial lawyers watch to gauge how juries react to shared evidence. The split helps explain both sides of the proposal. Plaintiffs face real trial risk, while J&J faces large verdicts if more juries side with plaintiffs.
What to do if you used the powder
You cannot buy new talc Johnson's Baby Powder. J&J discontinued talc powder globally in 2023 and moved the portfolio to cornstarch, while continuing to assert that its talc was safe and asbestos-free, according to the company's 2022 notice.
If you have an ovarian or gynecologic diagnosis and a history of talc use, practical steps help: Do not stop medical care to pursue a claim. A lawyer evaluates legal fit, while doctors evaluate diagnosis and treatment.
- list the products, years, and frequency of use
- gather pathology, surgery, and treatment records
- ask a mass-tort attorney whether your claim fits the proposal group
- track response deadlines, since the 95% participation rule makes each decision count
What limits still apply to a claim
A hazard label is not proof for one person. In July 2024, WHO's IARC classified talc as Group 2A, probably carcinogenic, based on limited human ovarian-cancer evidence, as reported by MesoWatch. That classification describes a hazard across studies.
It does not prove that talc caused any individual's cancer. State filing deadlines still apply, and trial outcomes vary by facts and venue. Keep product memories, medical records, and legal mail together before you call counsel.
You Might Also Like
- Uber Sexual Assault Lawsuit: Where the MDL Stands in 2026
- Uber Sexual Assault Lawsuit: What Riders Can Claim in 2026
- Talcum Powder Lawsuit Eligibility: What Injuries Qualify for a Claim?